The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
Chia-Chi J. Lin
No relevant relationships to disclose
Chih-Hung Hsu
No relevant relationships to disclose
Jason C. Cheng
No relevant relationships to disclose
Chueh-Chuan Yen
No relevant relationships to disclose
Her-Shyong Shiah
No relevant relationships to disclose
Ta-Chen Huang
No relevant relationships to disclose
Wei-Wu Chen
No relevant relationships to disclose
Hsiu-Po Wang
No relevant relationships to disclose
Kun-Huei Yeh
No relevant relationships to disclose
Jang-Ming Lee
No relevant relationships to disclose
Ann-Lii Cheng
No relevant relationships to disclose